Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Non-Small-Cell Lung 8Triple Negative Breast Neoplasms 7Lung Neoplasms 7Breast Neoplasms 7Ovarian Neoplasms 5Neoplasm Metastasis 5Endometrial Neoplasms 5Pancreatic Neoplasms 4Fallopian Tube Neoplasms 4Adenocarcinoma Of Esophagus 4Squamous Cell Carcinoma of Head and Neck 3Melanoma 3Esophageal Neoplasms 3Esophageal Squamous Cell Carcinoma 2Colorectal Neoplasms 2Cholangiocarcinoma 2Carcinoma, Transitional Cell 2Brenner Tumor 2Anatomic Stage I Breast Cancer AJCC v8 2Urinary Bladder Neoplasms 1Small Cell Lung Carcinoma 1Sinonasal Squamous Cell Carcinoma 1Rectal Neoplasms 1Pancreatic Cystic Neoplasm 1Oropharyngeal Neoplasms 1Neoplasms 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Metastatic Pancreatic Ductal Adenocarcinoma 1Locally Advanced Cervical Adenocarcinoma 1

Interventions

Cisplatin 6Paclitaxel 4pembrolizumab 3Fluorouracil 3Carboplatin 3tislelizumab 2Taxes 2Radiotherapy 2Oxaliplatin 2Leucovorin 2Irinotecan 2Injections 2Capecitabine 2130-nm albumin-bound paclitaxel 2spartalizumab 1lenvatinib 1durvalumab 1cixutumumab 1apatinib 1Tegafur 1Surgical Procedures, Operative 1Saline Solution 1Radiation 1Levoleucovorin 1Laparoscopy 1Histamine H2 Antagonists 1Histamine Antagonists 1Fulvestrant 1Docetaxel 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Esophageal Squamous Cell Carcinoma × Taxes × 30 days × Clear all
NCT07618910 2026-06-01

Retlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCC

Tang-Du Hospital

Phase 2 Not yet recruiting
33 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT01142388 2026-05-29

Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
94 enrolled 8 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡